ARDX- Ardelyx, Inc.
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $21.04M | - | |
| CEO | 1.74M | $11.09M | -41,666 | |
| Other | 409.9K | $2.61M | - | |
| CFO | 409.1K | $2.61M | - | |
| Other | 339.5K | $2.16M | - |
Activity
Buys and sells only
Transactions
10 filings · page 24
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | Grammer Elizabeth A58 | See Remarks | Sale+OE | 42,000 | $7.30 | $306,600.00 | -22.5% | |
| Dec 10, 2020 | Mott David M88 | Director | Buy | 170,000 | $5.89 | $1,000,841.00 | +68.7% | |
| Sep 16, 2020 | Rodriguez Susan45 | Chief Commercial Officer | Sell | 6,087 | $6.11 | $37,164.18 | -30.4% | |
| Sep 16, 2020 | Jacobs Jeffrey W66 | SVP, Technical Operations | Sell | 50,804 | $5.63 | $286,088.99 | -20.0% | |
| Sep 15, 2020 | Blanks Robert | See Remarks | Sell | 34,685 | $5.45 | $189,182.40 | -30.1% | |
| Sep 15, 2020 | Rosenbaum David P.59 | Chief Development Officer | Sell | 38,126 | $5.52 | $210,432.27 | -19.8% | |
| Sep 15, 2020 | Renz Justin A54 | Chief Financial Officer | Sell | 3,714 | $5.49 | $20,372.78 | -28.6% | |
| Sep 15, 2020 | Raab Michael56 | President &CEO | Sell | 106,337 | $5.61 | $596,284.73 | -50.4% | |
| Sep 15, 2020 | Grammer Elizabeth A58 | See Remarks | Sell | 28,810 | $5.37 | $154,574.29 | -28.4% | |
| Sep 1, 2020 | Blanks Robert | See Remarks | Sell | 2,049 | $5.58 | $11,425.02 | -1.7% |